{
  "task_id": "task-004",
  "agent_name": "bio-reasoning-agent",
  "summary": "Audit found 2 contradictions: 1 internal contradiction between claims, 1 contradiction with established knowledge.",
  "claims": [
    {
      "id": "claim-001",
      "text": "TP53 is a tumor suppressor that prevents uncontrolled cell growth.",
      "entities": [
        {
          "mention": "TP53",
          "norm_id": "HGNC:11998",
          "norm_label": "tumor protein p53",
          "source": "dictionary",
          "metadata": {}
        }
      ],
      "support_span": "TP53 is well-established as a tumor suppressor.",
      "evidence": ["PMID:12345678"],
      "metadata": {
        "confidence": 0.99,
        "extraction_method": "rule"
      }
    },
    {
      "id": "claim-002",
      "text": "TP53 promotes tumor formation and cancer progression.",
      "entities": [
        {
          "mention": "TP53",
          "norm_id": "HGNC:11998",
          "norm_label": "tumor protein p53",
          "source": "dictionary",
          "metadata": {}
        }
      ],
      "support_span": null,
      "evidence": [],
      "metadata": {
        "confidence": 0.5,
        "extraction_method": "llm"
      }
    },
    {
      "id": "claim-003",
      "text": "BRAF V600E mutation is not associated with melanoma.",
      "entities": [
        {
          "mention": "BRAF",
          "norm_id": "HGNC:1097",
          "norm_label": "B-Raf proto-oncogene, serine/threonine kinase",
          "source": "dictionary",
          "metadata": {}
        },
        {
          "mention": "V600E mutation",
          "norm_id": "ClinVar:13961",
          "norm_label": "BRAF p.Val600Glu",
          "source": "dictionary",
          "metadata": {
            "hgvs": "NP_004324.2:p.Val600Glu"
          }
        },
        {
          "mention": "melanoma",
          "norm_id": "MONDO:0005105",
          "norm_label": "melanoma",
          "source": "dictionary",
          "metadata": {}
        }
      ],
      "support_span": null,
      "evidence": [],
      "metadata": {
        "confidence": 0.3,
        "extraction_method": "llm"
      }
    }
  ],
  "findings": [
    {
      "id": "finding-001",
      "kind": "contradiction",
      "severity": "error",
      "message": "Internal contradiction: claim-001 states TP53 is a tumor suppressor that prevents cell growth, while claim-002 states TP53 promotes tumor formation. These claims are mutually exclusive.",
      "claim_id": "claim-002",
      "provenance": {
        "rule_id": "rule-contradiction-detection",
        "rule_name": "Detect contradictory claims about same entity",
        "evidence_ids": ["claim-001", "claim-002"]
      },
      "suggested_fix": {
        "target_claim_id": "claim-002",
        "patch": "Remove or correct claim-002. TP53 is a well-established tumor suppressor. Note: Gain-of-function TP53 mutants can have oncogenic properties, but wild-type TP53 suppresses tumors. Clarify whether referring to wild-type or mutant TP53.",
        "rationale": "The two claims about TP53 function are contradictory. Claim-001 aligns with established knowledge.",
        "confidence": 0.95,
        "metadata": {
          "dominant_claim": "claim-001",
          "resolution": "retain_claim-001"
        }
      }
    },
    {
      "id": "finding-002",
      "kind": "contradiction",
      "severity": "blocker",
      "message": "Contradiction with established knowledge: BRAF V600E is strongly associated with melanoma (found in ~50% of melanomas). The claim that it is 'not associated' contradicts extensive literature and clinical evidence.",
      "claim_id": "claim-003",
      "provenance": {
        "rule_id": "rule-kg-contradiction",
        "rule_name": "Check claims against knowledge graph",
        "kg_source": "ClinVar,COSMIC,DisGeNET",
        "kg_query": "SELECT ?disease WHERE { ClinVar:13961 :associatedWith ?disease }",
        "evidence_ids": ["PMID:12068308", "PMID:20818844", "COSMIC:BRAF"]
      },
      "suggested_fix": {
        "target_claim_id": "claim-003",
        "patch": "Remove or invert this claim. BRAF V600E is one of the most common mutations in melanoma and is a validated therapeutic target (e.g., vemurafenib, dabrafenib).",
        "rationale": "This claim directly contradicts well-established clinical knowledge with extensive evidence.",
        "confidence": 0.99,
        "metadata": {
          "supporting_evidence": ["PMID:12068308", "PMID:20818844"],
          "prevalence": "~50% of melanomas"
        }
      }
    }
  ],
  "suggested_fixes": [],
  "stats": {
    "total_claims": 3,
    "total_findings": 2,
    "findings_by_severity": {
      "error": 1,
      "blocker": 1
    },
    "findings_by_kind": {
      "contradiction": 2
    },
    "entities_normalized": 5,
    "entities_unresolved": 0
  }
}
